Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Abstract
Abstract
Tabla A
Balkis, M., Leidich, S., Mukherjee, P., & Ghannoum, M. (2002). Mechanism of fungal resistance. Drugs, 62:
1025-1040.
Debnath, S., & Addya, S. (2014). Structural basis for heterogeneous phenotype of ERG11 dependent Azole
resistance in C.albicans clinical isolates. SpringerPlus, 3:660.
Fuentes, M., H, G., Alburquenque, C., Falconer, M. A., Amaro, J., & Tapia, C. (2014). Caracterización de los
mecanismos de resistencia a azoles en cepas clínicas chilenas de Candida albicans. Revista Chilena
de Infectología. Vol 31, 511-517.
Jones, T. F. (16 de abril de 2004). ncbi. Candida albicans SC5314 chromosome 5 Ctg19-10080, whole
genome shotgun sequence. Stanford, California. Recuperado el 28 de noviembre de 2014, de ncbi:
http://www.ncbi.nlm.nih.gov/nuccore/NW_139483.1?from=8338&to=9924&report
Lockhart, S., Lqbal, N., Cleveland, A., Farley, M., Harrison, L., & Bolden, C. (2012). Species identification
and antifungal susceptibility testing of Candida bloodstream isolates from population-based
surveillance studies in two U.S cities from, 2008 to 2011. Journal of Clinical Microbiology, 435-
442.
Mariceli, R., & Claudete, P. (2007). Up-regulation of ERG11 gene among fluoconazole-resistant Candida
albicans generated in vitro: is there any clinical implications? Diagnostic Microbiology and
Infectious Disease, 71-75.
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., . . . Bossche, H. (1999).
Contribution of mutations in the cytochrome P450 14alpha-demethylase (ERG11p. CYP51p) to
azole resistance in Candida albicans . Microbiology, 145: 2701-2713.
Morio, F., Loge, C., Besse, B., Hannequin, C., & Le Pape, P. (2010). Screening for amino acid substitutions
in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new
substitutions and a review of the literature. Diagnostic Microbiology and Infectious Disease, 373-
384.
Perea, S. (2000). Resistencia de Candida albicans a los azoles. Revista Española de Quimioterapia. 13(3).
Tan J, Z. J. (15 de noviembre de 2014). The A395T Mutation in ERG11 Gene Confers Fluconazole
Resistance in Candida tropicalis Causing Candidemia. Beijing: Department of Dermatology, Peking
University First Hospital, Research Center for Medical Mycology, Peking University, , People.
Recuperado el 28 de noviembre de 2014, de http://www.ncbi.nlm.nih.gov/pubmed/25398256
Van den Bossche, H., Willemsens, G., Cools, W., Lauwers, W. F., & Le Jeune, L. (1978). Biochemical effects
of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chemico-
biological interactions, 59-78.
Vanden, B. H., Dromer, F., Improvisi, I., Lozano-Chiu, M., Rex, J. H., & Sanglard, D. (1997). Antifungal
drug resistance in pathogenic fungi. Medical Mycology, 119-128.
Vandeputte, P., Ferrari, S., & Coste, A. (2012). Antifungal resistance and new strategies to control fungal
infections. International Journal of Microbiology.
Yonghao, X., Lamei, C., & Chunyang, L. (2008). Susceptibility of clinical isolates of Candida species to
fluconazole and detections of Candida albicans ERG11 mutations. Journal of Antimicrobial
Chemotherapy 61, 798-804.